MOTCO’s ResMed RMD Stock Holding History

MOTCO’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-73	Closed	-$16.3K	–	676
2025 Q1	$16.3K	Buy	+73	New	+$17K	﹤0.01%	389
2024 Q1	–	Sell	-1	Closed	-$172	–	766
2023 Q4	$172	Hold	1	–	–	﹤0.01%	700
2023 Q3	$148	Sell	1 -2	-67%	-$362	﹤0.01%	775
2023 Q2	$656	Buy	+3	New	+$669	﹤0.01%	823
2021 Q1	–	Sell	-11	Closed	-$2K	–	765
2020 Q4	$2K	Hold	11	–	–	﹤0.01%	695
2020 Q3	$2K	Hold	11	–	–	﹤0.01%	602
2020 Q2	$2K	Hold	11	–	–	﹤0.01%	560
2020 Q1	$2K	Buy	+11	New	+$1.75K	﹤0.01%	558
2019 Q3	–	Sell	-23	Closed	-$3K	–	702
2019 Q2	$3K	Buy	+23	New	+$2.55K	﹤0.01%	774

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

MOTCO's RMD Position: Q2 2025 in Review

MOTCO sold out of ResMed (RMD) in Q2 2025, closing a stake of 73 shares — an estimated $16.3K sold.

MOTCO first reported a position in RMD in Q2 2019 and held it in 9 quarters. The position peaked at $16.3K in Q1 2025. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

MOTCO reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
MOTCO sold 73 ResMed shares in Q2 2025, an estimated $16.3K.
MOTCO first reported a position in ResMed in Q2 2019 and held it in 9 quarters.
MOTCO's ResMed position peaked at $16.3K in Q1 2025.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on MOTCO's 13F filing for Q2 2025, filed 1 Aug 2025.